Dicerna, Celladon, Eagle amend IPOs

RNAi play Dicerna Pharmaceuticals Inc. (Watertown, Mass.), gene therapy company Celladon Corp. (San Diego, Calif.) and drug delivery company Eagle Pharmaceuticals Inc. (Woodcliff Lake, N.J.) all amended planned IPOs on NASDAQ. Dicerna bumped up

Read the full 340 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE